CA2867557C - Peptides for management of lactation - Google Patents

Peptides for management of lactation Download PDF

Info

Publication number
CA2867557C
CA2867557C CA2867557A CA2867557A CA2867557C CA 2867557 C CA2867557 C CA 2867557C CA 2867557 A CA2867557 A CA 2867557A CA 2867557 A CA2867557 A CA 2867557A CA 2867557 C CA2867557 C CA 2867557C
Authority
CA
Canada
Prior art keywords
peptide
seq
ser
amino acid
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2867557A
Other languages
English (en)
French (fr)
Other versions
CA2867557A1 (en
Inventor
Jose Mario Iscovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of CA2867557A1 publication Critical patent/CA2867557A1/en
Application granted granted Critical
Publication of CA2867557C publication Critical patent/CA2867557C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA2867557A 2012-03-19 2013-03-08 Peptides for management of lactation Active CA2867557C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612410P 2012-03-19 2012-03-19
US61/612,410 2012-03-19
PCT/IL2013/050214 WO2013140388A1 (en) 2012-03-19 2013-03-08 Peptides for management of lactation

Publications (2)

Publication Number Publication Date
CA2867557A1 CA2867557A1 (en) 2013-09-26
CA2867557C true CA2867557C (en) 2020-03-10

Family

ID=49221927

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2867557A Active CA2867557C (en) 2012-03-19 2013-03-08 Peptides for management of lactation

Country Status (11)

Country Link
US (1) US9487557B2 (enExample)
EP (1) EP2828281B1 (enExample)
JP (1) JP6426599B2 (enExample)
CN (1) CN104321336B (enExample)
AU (1) AU2013236975B2 (enExample)
BR (1) BR112014023087A8 (enExample)
CA (1) CA2867557C (enExample)
ES (1) ES2759980T3 (enExample)
IL (1) IL234574B (enExample)
IN (1) IN2014DN08610A (enExample)
WO (1) WO2013140388A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
CN114727624A (zh) 2019-11-28 2022-07-08 勃林格殷格翰动物保健有限公司 Sglt-2抑制剂在非人哺乳动物的停奶中的用途
US20240207352A1 (en) * 2021-04-28 2024-06-27 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391849B1 (en) 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
EP1375513A4 (en) * 2001-03-09 2006-04-12 Meiji Seika Kaisha IMMUNOSTIMULANTS
CN101247721B (zh) * 2005-05-02 2016-08-03 米勒尤迪斯公司 包括酪蛋白衍生肽的药物组合物及其使用方法
AU2006242842B2 (en) 2005-05-02 2011-12-08 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
MX2010001684A (es) * 2007-08-15 2010-04-21 Amunix Inc Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos.

Also Published As

Publication number Publication date
EP2828281A1 (en) 2015-01-28
US9487557B2 (en) 2016-11-08
CN104321336A (zh) 2015-01-28
JP6426599B2 (ja) 2018-11-21
EP2828281A4 (en) 2015-11-11
AU2013236975B2 (en) 2017-10-19
IN2014DN08610A (enExample) 2015-05-22
IL234574B (en) 2020-09-30
JP2015516377A (ja) 2015-06-11
CA2867557A1 (en) 2013-09-26
CN104321336B (zh) 2021-08-06
BR112014023087A8 (pt) 2018-01-16
US20150093400A1 (en) 2015-04-02
BR112014023087A2 (pt) 2017-06-20
EP2828281B1 (en) 2019-09-18
WO2013140388A1 (en) 2013-09-26
ES2759980T3 (es) 2020-05-12
AU2013236975A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
US8338363B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
JP2008509073A (ja) カゼイン由来ペプチドおよびその治療的使用
US20240158442A1 (en) Multifunctional polypeptide and application thereof in field of medicines
US20240002435A1 (en) Synthetic peptide and application thereof
AU2013236975B2 (en) Peptides for management of lactation
US9249188B2 (en) Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
CN101247721B (zh) 包括酪蛋白衍生肽的药物组合物及其使用方法
AU2012200889B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
RU2582965C9 (ru) Фармацевтическая композиция для лечения эндометриоза и способ ее получения
CN106117315B (zh) 五肽在治疗金葡菌奶牛乳房炎中的医用用途
CN106188233B (zh) 一种治疗金葡菌奶牛乳房炎的多肽及制备工艺
IL222486A (en) Casein-derived peptides and methods for using them to enhance milk cleanliness
IL222487A (en) Casein-derived peptides and methods for using them to increase milk yield
IL187120A (en) Casein-derived peptides and methods for their use in the herd's interface with milk

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180110

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241212

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241212

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251202

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251202